Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Biopharm Stat ; 27(1): 111-123, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-26881877

RESUMO

In clinical studies, ordered categorical responses are common. To compare the efficacy of several treatments with a control for ordinal responses, the normal latent variable model has recently been proposed. This approach conceptualizes the responses as manifestations of an underlying continuous normal variable. In this article, we extend this idea to develop the multiple comparison method for use when there are two controls in the clinical trial. The proposed method is constructed such that the familywise type I error rate is controlled at a prespecified level. In addition, for a given level of test power, the procedure to evaluate the required sample size is provided. The proposed testing procedure is also illustrated by an example from a clinical study.


Assuntos
Ensaios Clínicos como Assunto , Modelos Estatísticos , Projetos de Pesquisa , Humanos , Tamanho da Amostra
2.
Stat Methods Med Res ; 26(3): 1295-1307, 2017 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-25792542

RESUMO

The increasing popularity of noninferiority trials reflects the ongoing efforts to replace existing treatments (reference treatments) with new treatments (experimental treatments) that retain a substantial fraction of the effect of the reference treatments. The adoption of any new treatment has to be vindicated by a demonstration of benefits that outweigh a possible clinically insignificant reduction in the reference treatment efficacy. Statistical methods have been developed to analyze data collected from noninferiority trials. However, these methods focus on cases with only one reference treatment. In this paper, we provide the statistical inferential procedures for situations with multiple reference treatments. The computation of the corresponding critical values for simultaneous testings of noninferiority of several new treatments to multiple reference treatments in the presence of a placebo is provided. Furthermore, for a prespecified level of test power, a technique to determine the optimal sample size before the onset of a noninferiority trial is derived. A clinical example is given to illustrate our proposed procedure.


Assuntos
Estudos de Equivalência como Asunto , Projetos de Pesquisa , Benzimidazóis/farmacologia , Benzimidazóis/uso terapêutico , Pressão Sanguínea/efeitos dos fármacos , Humanos , Hipertensão/tratamento farmacológico , Imidazóis/farmacologia , Imidazóis/uso terapêutico , Oxidiazóis/farmacologia , Oxidiazóis/uso terapêutico , Padrões de Referência , Tamanho da Amostra , Tetrazóis/farmacologia , Tetrazóis/uso terapêutico , Resultado do Tratamento , Valsartana/farmacologia , Valsartana/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...